Cristina Csimma Net Worth

Cristina Csimma biography

Dr. Cristina Csimma Pharm.D. serves as Independent Director of the Company. She also serves on the Board of Directors of Idera Pharmaceuticals (NASDAQ: IDRA), a clinical stage biopharmaceutical company and T1D Exchange, a nonprofit research organization for type 1 diabetes. She also serves on various advisory boards, including: the Muscular Dystrophy Association Venture Philanthropy Scientific Advisory Committee; the Executive Oversight Board to the National Institutes of Health (NIH) NeuroNext Network; the Harvard and Brigham and Women’s Hospital MRCT Center External Advisory Board, and the TREAT-NMD Advisory Committee for Therapeutics (TACT) She was previously the Executive Chair of the Board of Directors of Exonics Therapeutics, a Director of Juniper Pharmaceuticals (acquired in August 2018 by Catalent), Vtesse (acquired in March 2017 by Sucampo Pharmaceuticals) and Cydan, where she was also President and founding CEO, the Vice President of Drug Development at Virdante Pharmaceuticals Inc (acquired by Momenta), Principal at Clarus Ventures LLC, and held roles in Clinical Development and Translational Research at Wyeth (now Pfizer), Genetics Institute and Dana Farber Cancer Institute. Dr. Csimma holds both a Doctor of Pharmacy and a Bachelor of Science in Pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences, as well as a Master of Health Professions from Northeastern University. In selecting Dr. Csimma, the board took into account her vast experience in the pharmaceutical industry, including her successes in developing drugs for various diseases throughout her career.

How old is Cristina Csimma?

Cristina Csimma is 61, he's been the Independent Director of Seneca Biopharma Inc since 2017. There are 7 older and 5 younger executives at Seneca Biopharma Inc. The oldest executive at Seneca Biopharma Inc is Stanley Westreich, 81, who is the Independent Director.

What's Cristina Csimma's mailing address?

Cristina's mailing address filed with the SEC is C/O IDERA PHARMACEUTICALS, INC., 505 EAGLEVIEW BOULEVARD, SUITE 212, EXTON, PA, 19341.

What does Seneca Biopharma Inc do?

Seneca Biopharma Inc executives and stock owners

Seneca Biopharma Inc executives and other stock owners filed with the SEC include:

• Dr. Kenneth C. Carter,
  Exec. Chairman & CEO
• Stanley Westreich,
  Independent Director
• Binxian Wei,
  Independent Director
• Sandford Smith,
  Independent Director
• Scott Ogilvie,
  Independent Director
• Cristina Csimma,
  Independent Director
• David Mazzo,
  Director
• Mary Gray,
  Director
• Dane Saglio,
  Chief Financial Officer, Principal Accounting Officer
• Matthew Kalnik,
  President, Chief Operating Officer
• Kenneth Carter,
  Executive Chairman, Principal Executive Officer
• Dr. David P. Recker FACR, M.D., FACP,
  Chief Medical Officer
• Dr. Thomas G. Hazel,
  Sr. VP of R&D
• Dr. Karl Y. Johe,
  Co-Founder